Guideline-changing trial results released earlier in 2019 suggest that SGLT2 inhibitors could be a viable treatment solution for patients with diabetes and evidence of kidney damage.
Power of one: what is holding polypills back?Subscription
Single pills with fixed-dose combinations of several medicines are not commonplace for the treatment of cardiovascular disease. As the first randomised controlled trial to show a polypill can cut the risk of heart attacks is published, we look at why, nearly two decades after it was first proposed, development and uptake is limited.
Case-based learning: sore throatSubscription
Most sore throats are caused by viral infections and get better within a week through self-care. However, it is important to recognise when a sore throat is a symptom of a more serious illness.
Should pharmacies be able to supply high-dose statins without a prescription?
Some patients teach a valuable lesson that endures for an entire professional career, and in 2019, Electronicjuice challenged pharmacists to describe the patient who changed their practice, in no more than 500 words. And they did not disappoint. We were pleased to receive so many brilliant entries from pharmacists, and those in training, and we hope you enjoy reading our selection of the best.